In a type 1 diabetic patient on a 6‑unit basal insulin regimen whose blood glucose is not at goal, what should be done next?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Increase the Basal Insulin Dose by 2 Units Every 3 Days Until Fasting Blood Glucose Reaches Goal

If 6 units of basal insulin is not achieving blood glucose goals in a type 1 diabetic patient, you should systematically titrate the basal insulin upward using an evidence-based algorithm: increase by 2 units every 3 days until the fasting plasma glucose (FPG) reaches the individualized target without causing hypoglycemia 1.

Immediate Action Steps

The 2025 ADA Standards of Care provide a clear titration protocol 1:

  • Increase basal insulin by 2 units every 3 days
  • Set a specific FPG goal (typically 90-130 mg/dL for most nonpregnant adults)
  • Monitor for hypoglycemia at each adjustment
  • If hypoglycemia occurs without a clear precipitating cause, reduce the dose by 10-20%

Why This Approach

Starting at 6 units is actually below the typical recommended starting dose of 10 units daily or 0.1-0.2 units/kg/day 1. This patient is likely significantly under-insulinized, which is why blood glucose remains uncontrolled.

The key principle is to avoid therapeutic inertia - reassess and modify the regimen every 3-6 months, or more frequently when clearly not at goal 1.

Monitoring During Titration

At every visit, assess for clinical signals that indicate:

  • Whether the basal dose is adequate
  • Signs of "overbasalization" (elevated bedtime-to-morning differential, postprandial spikes)
  • Hypoglycemia (aware or unaware)
  • High glucose variability

When Basal Insulin Alone Is Insufficient

If after optimizing basal insulin the A1C remains above goal, you'll need to add prandial insulin 1:

  • Start with 4 units of rapid-acting insulin before the largest meal or the meal causing the greatest postprandial glucose excursion
  • Alternatively, use 10% of the basal insulin dose as the starting prandial dose
  • Titrate by increasing 1-2 units or 10-15% based on postprandial glucose readings

Type 1 Diabetes Requires Intensive Insulin Therapy

Unlike type 2 diabetes where you might start conservatively, type 1 diabetes requires intensive insulin treatment from the outset - this means multiple daily injections combining basal and bolus insulin or continuous subcutaneous insulin infusion 2, 3. A single 6-unit basal dose without prandial coverage is inadequate for most type 1 diabetic patients.

Common Pitfall to Avoid

The most critical error here is therapeutic inertia - leaving the patient on an insufficient dose for too long. The guideline explicitly warns against this 1. Don't wait months to uptitrate; use the systematic 2-unit increase every 3 days until FPG is controlled, then address postprandial glucose with prandial insulin as needed.

References

Research

Type 1 Diabetes: Management Strategies.

American family physician, 2018

Research

Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.